Emerging Technologies in Transdermal Drug Delivery

Register now

About The Conference

The International Conference on Emerging Technologies in Transdermal Drug Delivery provides an opportunity for academics and industry to interact in a unique international environment to develop, implement, and transfer the latest generation of transdermal drug delivery technologies. Researchers at all levels can interact through oral presentations, dynamic poster sessions, and networking opportunities. A key focus of the conference will be the advancement and innovation of transdermal and microneedle systems for therapeutic drug delivery, the exploration of device application and an overview of the current global regulatory medical devices landscape.

• Advances in Topical and Transdermal Drug Delivery
•Microneedle Technologies and Future Directions
•Overview of he Current Global Regulatory Landscape

Key Deadlines
• FEBRUARY 28, Deadline for abstract submission
•MARCH 10, Acceptance/Rejection Notification
•MARCH 17, Final Program


Call for Contributions

We invite you to submit high quality research contributions describing original results of
advances in topical and transdermal drug delivery, microneedle technologies, explorations of innovative applications and analysis of global regulatory requirements in all areas of emerging technologies of transdermal drug delivery. We invite abstracts and posters that address conference themes and topics.

Submission Requirements

Abstract submission must include a presentation title, a list of authors and their affiliations, and a brief text that adequately describes the work done and conclusions achieved. Contributions could be presented through oral presentations or posters indicating the keywords. Presenting authors must submit their abstract to the conference within the 28th of February 2023. Notifications of acceptance or rejection will be communicated to the presenting author by 10th of March 2023.


The abstract must have the following characteristics:
Submit as a PDF.
Submissions must be in English.
The length of all submissions should not exceed 500 words, excluding the title, authors, affiliations, and references.
Title, authors, affiliations, and main narrative text should be included in all submissions.


Abstract Submission




ICET2D2 is an opportunity for academics and industry to exchange the latest news on transdermal drug delivery technologies by Materias





anorexia covid19 design event evento Fabio De Furia florida Genius health lazio medicine miami miami dade miamisic nanotechnology PMI research small industry startups